Marco Gambarotti

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial

Giovanni Grignani, Emanuela Palmerini, Virginia Ferraresi et al. · The Lancet Oncology · 2014 · 328 citations · Full text

Surgical Oncology, Medicine, Standard Treatment +6

Positively selected enhancer elements endow osteosarcoma cells with metastatic competence

James J. Morrow, Ian Bayles, Alister P. W. Funnell et al. · Nature Medicine · 2018 · 172 citations · Full text

Oncology, Bone Morphogenic Protein, Medicine +5

Variability of Histologic Lesions in Relation to Biopsy Site in Gluten-Sensitive Enteropathy

Alberto Ravelli, S. Bolognini, Marco Gambarotti et al. · The American Journal of Gastroenterology · 2005 · 169 citations

Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors

Emanuela Palmerini, Eric L. Staals, Robert G. Maki et al. · European Journal of Cancer · 2014 · 136 citations

Villonodular Synovitis, Surgical Pathology, Immunology +5

Coeliac disease: a histological follow‐up study

Maria Teresa Bardella, P. Velio, Bruno Mario Cesana et al. · Histopathology · 2007 · 125 citations